In the last trading session, 2.42 million shares of the Adicet Bio Inc (NASDAQ:ACET) were traded, and its beta was 1.91. Most recently the company’s share price was $0.54, and it changed around $0.09 or 20.11% from the last close, which brings the market valuation of the company to $44.40M. ACET currently trades at a discount to its 52-week high of $2.35, offering almost -335.19% off that amount. The share price’s 52-week low was $0.45, which indicates that the current value has risen by an impressive 16.67% since then. We note from Adicet Bio Inc’s average daily trading volume that its 10-day average is 0.77 million shares, with the 3-month average coming to 788.70K.
Adicet Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.57. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended ACET as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Adicet Bio Inc is expected to report earnings per share of -0.34 for the current quarter.
Adicet Bio Inc (NASDAQ:ACET) trade information
Instantly ACET has showed a green trend with a performance of 20.11% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6656 on recent trading dayincreased the stock’s daily price by 18.87%. The company’s shares are currently down -44.18% year-to-date, but still down -15.92% over the last five days. On the other hand, Adicet Bio Inc (NASDAQ:ACET) is -30.79% down in the 30-day period. We can see from the shorts that 2.85 million shares have been sold at a short interest cover period of 8.51 day(s).
The consensus price target as assigned by Wall Street analysts is $32.5, which translates to bulls needing to increase their stock price by 98.34% from its current value. Analyst projections state that ACET is forecast to be at a low of $27 and a high of $38.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 36.74%. Adicet Bio Inc earnings are expected to increase by -14.39% in 2025, but the outlook is positive 5.15% per year for the next five years.
ACET Dividends
Adicet Bio Inc’s next quarterly earnings report is expected to be released on 2025-Mar-05.
Adicet Bio Inc (NASDAQ:ACET)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.74% of Adicet Bio Inc shares, and 69.24% of them are in the hands of institutional investors. The stock currently has a share float of 71.18%. Adicet Bio Inc stock is held by 76.0 institutions, with ORBIMED ADVISORS LLC being the largest institutional investor. By 2024-06-30, it held 12.6303% of the shares, which is about 11.45 million shares worth $13.85 million.
TANG CAPITAL MANAGEMENT LLC, with 9.0663% or 8.22 million shares worth $9.94 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.07 shares worth $1.11 million, making up 2.51% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 1.08 shares worth around $0.58 million, which represents about 1.31% of the total shares outstanding.
